PCVX logo

Vaxcyte (PCVX) Shareholders equity

annual shareholders equity:

$3.31B+$2.07B(+166.50%)
December 31, 2024

Summary

  • As of today (July 3, 2025), PCVX annual stockholders equity is $3.31 billion, with the most recent change of +$2.07 billion (+166.50%) on December 31, 2024.
  • During the last 3 years, PCVX annual shareholders equity has risen by +$3.02 billion (+1063.95%).
  • PCVX annual shareholders equity is now at all-time high.

Performance

PCVX Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXbalance sheet metrics

quarterly shareholders equity:

$3.20B-$105.79M(-3.20%)
March 31, 2025

Summary

  • As of today (July 3, 2025), PCVX quarterly stockholders equity is $3.20 billion, with the most recent change of -$105.79 million (-3.20%) on March 31, 2025.
  • Over the past year, PCVX quarterly shareholders equity has increased by +$1.22 billion (+61.29%).
  • PCVX quarterly shareholders equity is now -6.37% below its all-time high of $3.42 billion, reached on September 30, 2024.

Performance

PCVX quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPCVXbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

PCVX Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+166.5%+61.3%
3 y3 years+1064.0%+790.0%
5 y5 years+3207.8%+2221.4%

PCVX Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+1064.0%-6.4%+790.6%
5 y5-yearat high+3207.8%-6.4%+1026.7%
alltimeall timeat high+3207.8%-6.4%+3108.3%

PCVX Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$3.20B(-3.2%)
Dec 2024
$3.31B(+166.5%)
$3.31B(-3.3%)
Sep 2024
-
$3.42B(+72.1%)
Jun 2024
-
$1.99B(+0.1%)
Mar 2024
-
$1.98B(+59.9%)
Dec 2023
$1.24B(+30.1%)
$1.24B(-11.6%)
Sep 2023
-
$1.40B(-2.1%)
Jun 2023
-
$1.43B(+51.7%)
Mar 2023
-
$944.77M(-0.9%)
Dec 2022
$953.61M
$953.61M(+165.4%)
Sep 2022
-
$359.31M(-2.0%)
DateAnnualQuarterly
Jun 2022
-
$366.50M(+1.9%)
Mar 2022
-
$359.54M(+26.6%)
Dec 2021
$284.02M(-17.9%)
$284.02M(-7.2%)
Sep 2021
-
$305.96M(-3.5%)
Jun 2021
-
$317.02M(-3.0%)
Mar 2021
-
$326.94M(-5.5%)
Dec 2020
$345.84M(-425.1%)
$345.84M(-5.0%)
Sep 2020
-
$364.07M(-5.0%)
Jun 2020
-
$383.21M(+178.0%)
Mar 2020
-
$137.85M(-229.6%)
Dec 2019
-$106.37M(+84.3%)
-$106.37M
Dec 2018
-$57.73M
-

FAQ

  • What is Vaxcyte annual stockholders equity?
  • What is the all time high annual shareholders equity for Vaxcyte?
  • What is Vaxcyte annual shareholders equity year-on-year change?
  • What is Vaxcyte quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Vaxcyte?
  • What is Vaxcyte quarterly shareholders equity year-on-year change?

What is Vaxcyte annual stockholders equity?

The current annual shareholders equity of PCVX is $3.31B

What is the all time high annual shareholders equity for Vaxcyte?

Vaxcyte all-time high annual stockholders equity is $3.31B

What is Vaxcyte annual shareholders equity year-on-year change?

Over the past year, PCVX annual stockholders equity has changed by +$2.07B (+166.50%)

What is Vaxcyte quarterly stockholders equity?

The current quarterly shareholders equity of PCVX is $3.20B

What is the all time high quarterly shareholders equity for Vaxcyte?

Vaxcyte all-time high quarterly stockholders equity is $3.42B

What is Vaxcyte quarterly shareholders equity year-on-year change?

Over the past year, PCVX quarterly stockholders equity has changed by +$1.22B (+61.29%)
On this page